Table 1.
Indication | Number (%) |
---|---|
BRCA1 | |
Pathologic variant | 2 (2.7) |
VUS | 3 (4.1) |
BRCA2 | |
Pathologic variant | 9 (12.3) |
VUS | 2 (2.7) |
Other gene mutation | |
CDH1 | 1 (1.3) |
PALB2 | 1 (1.3) |
PALB2 VUS | 1 (1.3) |
Chest radiation therapy before age 30 | 2 (2.7) |
Risk model with LTR calculation ≥20% | |
Gail | 22 (30.1) |
Tyrer-Cuzick | 18 (24.7) |
Claus | 12 (16.4) |
BMRI: breast magnetic resonance imaging; VUS: variant of uncertain significance; LTR: lifetime risk.